A subtle shift might be more likely than re-regulation

New Stories

• Bayer makes another move into cell therapy

  August 22, 2019 - - Latest News

• Government could come for more given savings shortfall

  August 22, 2019 - - Latest News

• Patients might be hoping their medicine belongs to a large company

  August 22, 2019 - - Latest News

• Pfizer to invest US$500m in gene therapy manufacturing

  August 22, 2019 - - Latest News

• FDA rejects Sarepta's second RNA therapy

  August 21, 2019 - - Latest News

• PAGE co-founders on 'opening the door' to discussions on diversity

  August 21, 2019 - - Latest News

• Biogen backs new learning resource

  August 21, 2019 - - Latest News